We observed completely healthy livers free of tumours when FGF19-expressing Mdr2−/−mice were treated with anti-IL-6, whereas those treated with isotype control antibodies develop HCC (Fig. 7h,i and Supplementary Fig. 7k). The gene discussed is IL6; the disease is neoplasm.